Understanding vaccines: key scientific terms and platforms
Understanding Vaccines: Key Scientific Terms and Platforms Vaccines remain a cornerstone of public health strategies worldwide. However, understanding them requires familiarity with specific scientific terms and concepts. A report dated November 9, 2026, from a European regulatory agency provides an overview aimed at clarifying the science behind vaccines, their various technological platforms,…
Mandate, objectives, and rules of procedure for working parties under the quality, non-clinical, methodology, clinical and veterinary domains
Mandate and Objectives of EMA Working Parties in Pharmaceutical Domains This dossier reviews information from the European Medicines Agency (EMA) document titled “Mandate, objectives, and rules of procedure for working parties under the quality, non-clinical, methodology, clinical and veterinary domains,” published on November 9, 2026. The document outlines the organizational structure, roles,…
High-Profile Smuggling Raids in Hungary Point to Former PM's Brother
Accountability and High-Profile Smuggling Raids in Hungary: Evidence Dossier Accountability in High-Profile Smuggling Raids in Hungary: An Evidence Dossier What is established On November 9, 2026, Hungarian authorities conducted coordinated raids in Budapest and Pest County targeting a visa fraud and human smuggling network. Multiple suspects were arrested by units including the…
Paraguayan President Impeached and Arrested Amid Financial Meltdown and Mass Protests
Power and Money: The Impeachment of Paraguayan President Santiago Peña amid Financial Crisis On November 7, 2026, former Paraguayan President Santiago Peña was impeached and subsequently placed under house arrest amid mass protests stemming from a financial meltdown. The crisis centered around Ueno Bank, a digital financial institution closely linked to Peña…
Tanzanian Court Convicts Opposition Leader of Incitement
Tanzanian Opposition Leader Convicted for Incitement: An Evidence Dossier On November 6, 2026, Tanzania’s High Court convicted Tundu Lissu, leader of the main opposition party CHADEMA, of incitement. This dossier examines the available public evidence surrounding the conviction, highlights human rights concerns raised by observers, and considers broader political context and contested…
Rights on the Ballot Alongside US Congressional Elections
What is established On November 3, 2026, alongside the United States midterm elections, several state and local ballot measures directly addressed human rights issues. These initiatives covered a broad range of topics—including voting rights restoration, anti-discrimination protections, abortion access, transgender rights, and immigration enforcement policies. Voters across multiple states enacted or rejected…
New home for superheroes: Houghton Library
What is established Harvard University’s Houghton Library has received a significant donation of comic books from Reginald Hudlin, a Harvard alumnus and prominent filmmaker. The collection comprises nearly 25,000 comic book titles spanning from 1949 to 2025, including major publishers such as D.C. Comics, Marvel Comics, and others like Atlas, Charlton, and…
Concerns raised over older heavy drinkers
What is established Recent public health data from the Centers for Disease Control and Prevention (CDC) indicates that alcohol consumption patterns in the United States have shifted notably in the years following the COVID-19 pandemic. While younger adults have shown a decline in drinking rates, a contrasting trend appears among older adults,…
Human medicines European public assessment report (EPAR): Aldurazyme, laronidase, Date of authorisation: 09/06/2003, Revision: 28, Status: Authorised
What is established Aldurazyme is a medicinal enzyme replacement therapy containing the active substance laronidase. It is approved in the European Union for the treatment of mucopolysaccharidosis I (MPS I), a rare inherited metabolic disorder caused by a deficiency in the enzyme ?-L iduronidase. In patients with MPS I, this enzymatic deficiency…
Human medicines European public assessment report (EPAR): Yorvipath, palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 6, Status: Authorised
What is established Yorvipath is a hormone replacement therapy authorized by the European Medicines Agency (EMA) for treating adults with chronic hypoparathyroidism, a rare endocrine disorder characterized by insufficient production of parathyroid hormone (PTH). The active substance in Yorvipath is palopegteriparatide, which the body converts into teriparatide— a shorter form of PTH.…